Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 1
1997 1
1998 1
2001 3
2002 2
2003 2
2004 1
2005 5
2006 3
2007 7
2008 7
2009 4
2010 13
2011 27
2012 34
2013 37
2014 52
2015 77
2016 74
2017 76
2018 76
2019 76
2020 77
2021 66
2022 58
2023 20
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 25655625

673 results

Results by year

Filters applied: . Clear all
Page 1
18F-florbetapir PET in patients with frontotemporal dementia and Alzheimer disease.
Kobylecki C, Langheinrich T, Hinz R, Vardy ER, Brown G, Martino ME, Haense C, Richardson AM, Gerhard A, Anton-Rodriguez JM, Snowden JS, Neary D, Pontecorvo MJ, Herholz K. Kobylecki C, et al. J Nucl Med. 2015 Mar;56(3):386-91. doi: 10.2967/jnumed.114.147454. Epub 2015 Feb 5. J Nucl Med. 2015. PMID: 25655625 Free article.
Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease.
Fleisher AS, Chen K, Liu X, Roontiva A, Thiyyagura P, Ayutyanont N, Joshi AD, Clark CM, Mintun MA, Pontecorvo MJ, Doraiswamy PM, Johnson KA, Skovronsky DM, Reiman EM. Fleisher AS, et al. Arch Neurol. 2011 Nov;68(11):1404-11. doi: 10.1001/archneurol.2011.150. Epub 2011 Jul 11. Arch Neurol. 2011. PMID: 21747008
Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects.
Joshi AD, Pontecorvo MJ, Clark CM, Carpenter AP, Jennings DL, Sadowsky CH, Adler LP, Kovnat KD, Seibyl JP, Arora A, Saha K, Burns JD, Lowrey MJ, Mintun MA, Skovronsky DM; Florbetapir F 18 Study Investigators. Joshi AD, et al. J Nucl Med. 2012 Mar;53(3):378-84. doi: 10.2967/jnumed.111.090340. Epub 2012 Feb 13. J Nucl Med. 2012. PMID: 22331215 Free article.
Dual-phase [18F]florbetapir in frontotemporal dementia.
Asghar M, Hinz R, Herholz K, Carter SF. Asghar M, et al. Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):304-311. doi: 10.1007/s00259-018-4238-2. Epub 2018 Dec 19. Eur J Nucl Med Mol Imaging. 2019. PMID: 30569187 Free PMC article.
Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
Tateno A, Sakayori T, Kawashima Y, Higuchi M, Suhara T, Mizumura S, Mintun MA, Skovronsky DM, Honjo K, Ishihara K, Kumita S, Suzuki H, Okubo Y. Tateno A, et al. Int J Geriatr Psychiatry. 2015 May;30(5):505-13. doi: 10.1002/gps.4173. Epub 2014 Jul 7. Int J Geriatr Psychiatry. 2015. PMID: 25043833
Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and 18F-FDG-PET imaging.
Ottoy J, Niemantsverdriet E, Verhaeghe J, De Roeck E, Struyfs H, Somers C, Wyffels L, Ceyssens S, Van Mossevelde S, Van den Bossche T, Van Broeckhoven C, Ribbens A, Bjerke M, Stroobants S, Engelborghs S, Staelens S. Ottoy J, et al. Neuroimage Clin. 2019;22:101771. doi: 10.1016/j.nicl.2019.101771. Epub 2019 Mar 13. Neuroimage Clin. 2019. PMID: 30927601 Free PMC article.
673 results